Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


BioProspect targets Termilone approval

The Australian biotechnology company, BioProspect (Perth, Western Australia), hopes to receive Australian approval for its eremophilone oil-based termiticide, Termilone, within 12-18 months. The company plans to file its approval application in September, following the successful completion of its final mammalian toxicity study on acute inhalation. The “no toxicity” outcome concluded a two-year assessment carried out under OECD guidelines, BioProspect points out.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts